AI assistant
Sending…
Celldex Therapeutics, Inc. — Director's Dealing 2020
Jun 10, 2020
31801_dirs_2020-06-10_060caef4-696c-4418-b128-f09aaab0cccd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2020-06-09
Reporting Person: KELER TIBOR (Executive VP & CSO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-06-09 | Common Stock, par value $0.001 per share | P | 5000 | $2.9908 | Acquired | 7357 | Direct |
More from Celldex Therapeutics, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Prospectus
2026
Apr 2
Regulatory Filings
2026
Apr 2
Prospectus
2026
Apr 1
Major Shareholding Notification
2026
Mar 26